Manuscript Acceptance Rate: 20%
Lead Times for Original Research Articles: Submission to 1st Decision: < 2 weeks; Acceptance to Publish Ahead of Print: 4.5 weeks;  Acceptance to Print Publication: 8.5 weeks

Hypertension publishes scientific investigation of the highest quality in the broad field of blood pressure regulation and pathophysiology, clinical treatment, and prevention of hypertension. The editors encourage submission of original articles that deal with studies of hypertension and related fields such as nephrology, endocrinology, neuroscience, vascular biology, physiology, pharmacology, cellular and molecular biology, and genetics:
Basic Science
Research includes animal experiments, cell studies, biochemical, genetic and physiological investigations, and studies on the properties of drugs and materials. It also includes the development and improvement of analytical procedures, imaging procedures, gene sequencing, and the development of biometric procedures.
Clinical Science
Clinical research involves interactions with patients, diagnostic clinical materials or data, or populations in any of the following areas: (1) disease mechanisms (etiopathogenesis); (2) bi-directional integrative (translational) research; (3) clinical knowledge, detection, diagnosis and natural history of disease; (4) therapeutic interventions including clinical trials of drugs, biologics, devices and instruments; (5) prevention (primary and secondary) and health promotion; (6) behavioral research; and (7) health services research, including outcomes, and cost-effectiveness.
Population Science
Epidemiology is the science that investigates the patterns, causes, and effects of health versus disease in populations or patient cohorts. This involves, but is not limited to: (1) quantification and control of morbidity and mortality; (2) high-throughput “omics” and deep DNA sequencing; (3) longitudinal observations; (4) natural experiments (Mendelian randomization); (5) validation of potential disease-causing mechanisms identified in experimental studies and generating hypotheses for mechanisms to be tested in experimental studies; (6) use of “big data”, registries and “eHealth platforms”; and (7) systems biology and pathway analysis for integrating clinical with molecular data.

Editor-in-ChiefAnna F. Dominiczak
 
Deputy Editors
Rhian M. Touyz
Associate Editors
Gregory D. Fink
Joey P. Granger
David G. Harrison
Garry L.R. Jennings
S. Ananth Karumanchi
Jan A. Staessen
Ji-Guang Wang
Consulting Editors
Robert M. Carey
Gerald F. DiBona
Victor J. Dzau
David Ellison
Toshiro Fujita
John E. Hall
Norman M. Kaplan
Allyn L. Mark
L. Gabriel Navar
Suzanne Oparil

Statistical Consultant
John McClure
Lutgarde Thijs
Guest Editors
Morris J. Brown
David A. Calhoun
Marc L. De Buyzere
Bonita Falkner
Karen A. Griffin
Costantino Iadecola
Daniel W. Jones
Theodore A. Kotchen
Takayoshi Ohkubo
Pablo A. Ortiz
R. Clinton Webb

Social Media Team
Augusto C. Montezano, Team Lead
Brandi M. Wynne, Team Lead
Denise C. Cornelius
Tanja Dudenbostel
Carmen De Miguel
Georg Ehret
Hana A. Itani
Anastasia S. Mihailidou
Pablo Nakagawa
Francisco J. Rios
Frank T. Spradley